
Pacixone-S 1.5 Injection
Marketer
Adchem Biotech
Salt Composition
Ceftriaxone (1000mg) + Sulbactam (500mg)
Overview Pacixone-S 1.5 Injection
Combiflox-S 1.5 Injection, a dual-action antibiotic, combats diverse bacterial infections by inhibiting microbial proliferation and halting infection spread. Administer this injection solely under medical supervision; adhere strictly to the prescribed dosage schedule. Complete the entire treatment course, even with symptom improvement; premature cessation may reduce efficacy. Potential side effects include nausea, vomiting, diarrhea, and dyspepsia; worsening symptoms warrant immediate medical consultation. Seek urgent medical attention for allergic reactions (skin rashes, pruritus, edema, dyspnea). Inform your physician about all concurrent medications, particularly if pregnant or breastfeeding. Alcohol consumption should be avoided due to potential increased drowsiness. While generally non-impairing, refrain from driving if drowsiness or dizziness occurs. Adequate rest, nutrition, and hydration are crucial for optimal recovery. Your doctor may order blood tests and other assessments to monitor treatment response.
Uses of Pacixone-S 1.5 Injection
Infections caused by bacteria
Major Benefits of Pacixone-S 1.5 Injection:
This medication will be administered by your physician or their designated nurse; self-medication is strictly prohibited.
Common Side effects of Pacixone-S 1.5 Injection:
- Increased white blood cell count (eosinophils)
- Decreased white blood cell count (lymphocytes)
- Low blood platelets
- Rash
- Diarrhea
- Increased liver enzymes
- Injection site reactions (pain, swelling, redness)
How to use Pacixone-S 1.5 Injection:
This medication will be administered by your physician or their qualified staff. Self-medication is strongly discouraged.
How Pacixone-S 1.5 Injection works:
Ceftriaxone and Sulbactam, the components of Pacixone-S 1.5 Injection, act synergistically. Ceftriaxone's antibiotic action disrupts bacterial cell wall synthesis, hindering bacterial viability. Sulbactam, a beta-lactamase inhibitor, counteracts bacterial resistance mechanisms, thereby boosting Ceftriaxone's effectiveness.
SAFETY ADVICE
AlcoholSAFE
There are no known adverse reactions from concurrent use of Pacixone-S 1.5 Injection and alcohol.
PregnancySAFE IF PRESCRIBED
The injectable medication Pacixone-S 1.5 is generally deemed safe for use during pregnancy. Preclinical trials in animals revealed minimal or no harmful effects on fetal development; clinical data in humans, however, remain scarce.
Breast feedingCAUTION
Administering Pacixone-S 1.5 Injection to breastfeeding mothers requires careful consideration. Lactation should be discontinued for the duration of maternal treatment and until the medication is fully cleared from the mother's system.
DrivingUNSAFE
Pacixone-S 1.5 Injection can cause drowsiness, blurred vision, and dizziness. Driving is prohibited if these effects are experienced.
KidneyCONSULT YOUR DOCTOR
Insufficient data exists regarding Pacixone-S 1.5 Injection use in individuals with renal impairment. Physician consultation is recommended.
LiverCAUTION
Administering Pacixone-S 1.5 Injection requires careful consideration in individuals with severe hepatic impairment; dosage modification may be necessary. Physician consultation is advised. Dosage alteration for Pacixone-S 1.5 Injection is not suggested for patients exhibiting mild or moderate liver dysfunction.
What if you forget to take Pacixone-S 1.5 Injection :
Should you inadvertently omit a scheduled dose of Pacixone-S 1.5 Injection, seek immediate medical advice.
Facts to Know About Pacixone-S 1.5 Injection
| Label | Value |
|---|---|
| Addictive | None. |
| Medication Category | Drugs to fight infection |
